Modeling, building and evaluating an ontology for the automatic characterization of adverse drug effects during pharmacovigilance. - Inria - Institut national de recherche en sciences et technologies du numérique Accéder directement au contenu
Article Dans Une Revue Studies in Health Technology and Informatics Année : 2010

Modeling, building and evaluating an ontology for the automatic characterization of adverse drug effects during pharmacovigilance.

Résumé

BACKGROUND: The characterization of spontaneous reported cases is fundamental for pharmacovigilance. This task is time consuming and its reproducibility is low. OBJECTIVE: To develop a system founded on an ontology that automatically instantiates spontaneous reported cases as "known" adverse drug effects (ADE) only if the reported ADEs are described in drug compendia. METHODS: A simple ontology of drugs and their related adverse effects represented in description logics was developed from a drug database. Manual evaluation was carried out on 378 spontaneous reported cases instantiated as "known ADE of a chemical class". The initial manual characterization was reviewed by a pharmacovigilance expert to validate the generated automatic characterization. RESULTS: The ontology is composed by 57,04 concepts and 5 relations. It was successfully validated thanks to Pellet reasoner and it contains neither inconsistencies nor cycles. In this validation, 86% of the instantiated spontaneous reported cases effectively concerned notorious ADEs, whereas only 75% were initially identified manually as related to notorious ADEs. CONCLUSION: This system can assist characterization by applying a reasoning process similar to that used by experts in the search for ADEs.
Fichier non déposé

Dates et versions

hal-00845365 , version 1 (17-07-2013)

Identifiants

  • HAL Id : hal-00845365 , version 1
  • PUBMED : 20841835

Citer

Catherine Duclos, Lina F Soualmia, Sonia Krivine, Anne Jamet, Agnes Lillo-Louët. Modeling, building and evaluating an ontology for the automatic characterization of adverse drug effects during pharmacovigilance.. Studies in Health Technology and Informatics, 2010, 160 (Pt 2), pp.1005-9. ⟨hal-00845365⟩
163 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More